Development and evaluation of mitochondria-targeted caseinolytic protease (ClpP) agonist chemical probes in in vitro breast cancer models

Medicinal Chemistry Research · Published 2026-04-01 · DOI 10.1007/s00044-026-03551-4

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s00044-026-03551-4

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies · Medicinal Chemistry Research · 2026 · Same journal
Alisols A-C and their acetate derivatives: a review of natural occurrence, pharmacology, semisynthesis, pharmacokinetics, and metabolism · Medicinal Chemistry Research · 2026 · Same journal
Investigation of reported small molecule P2Y6 receptor antagonists · Medicinal Chemistry Research · 2026 · Same journal
Discovery of 3-(N-phenylsulfamoyl)-l-phenylalanine derivatives as novel and orally available LAT1-selective inhibitors · Medicinal Chemistry Research · 2026 · Same journal
From lipophilicity windows to decision-grade antibacterial design: the next translational step for coumarin amphiphiles · Medicinal Chemistry Research · 2026 · Same journal
Inactivation of ornithine aminotransferase by (1R,4S)-4-Amino-3-(trifluoromethyl)cyclopent-2-ene-1-carboxylic acid via a stable quinonoid intermediate · Medicinal Chemistry Research · 2026 · Same journal
Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights · Medicinal Chemistry Research · 2026 · Same journal
Synthesis and antihepatoma activity of dimeric 1-O-acetylbritannilactone derivatives · Medicinal Chemistry Research · 2026 · Same journal
Unrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease · Medicinal Chemistry Research · 2026 · Same journal
Development of new coumarin-piperazine-N-phenylacetamid derivatives as potent tyrosinase inhibitors: In vitro and in silico evaluations · Medicinal Chemistry Research · 2026 · Same journal